🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NEW: The White House is set to restart its free Covid test program, per 4 ppl familiar. Households will be able to order at-home tests again starting Tues from COVIDTests.gov as part of a broader Biden winter Covid plan. w David Lim: politico.com/news/2022/12/1…

Reading disruptive science. I think they mean 1/n sum from i=1 to n ( -2 f etc.)?

Any good TV show recommendations?

Dude. Why has trolling health insurance companies on Twitter become a thing? Like the fact that this works more quickly than calling is a huge problem.

😑

Lol, texting with my mom.

Opening up a slide deck I haven't worked on for a few weeks to see a placeholder slide, but no idea what I had in mind....

OK hear me out social medium for nerd losers called tikztok where we share latex figures

Is there absolute change in CDR-SB and centiloids for TRAILBLAZER-ALZ 2 for tx and placebo groups anywhere? Would love to find this to compare to CLARITY-AD and GRADUATE.

Check out our preprint! A Bayesian update of evidence on amyloid-targeting drugs. & Please do read the discussion in full. medrxiv.org/content/10.110…

The notion of a lab as a “family” is toxic. I think of my lab as a punk band, where I’m the grizzled old manager who goes around picking up bar tabs, cleaning up broken glass and vomit, and lying to the police

The COVID-19 pandemic may introduce period and mode effects, which could amplify the challenge of accounting for practice effects in cognitive aging research. In our new study, we compared different approaches to handling practice effects Alzheimer's & Dementia Journals (alz-journals.onlinelibrary.wiley.com/doi/epdf/10.10…)

1/n Ahead of the much anticipated FDA Adcom on #lecanemab we outline key questions that physicians, payors & regulators must ask in the assessment of anti-amyloid antibodies. tinyurl.com/yrtnb2et Robert Howard Kathy Liu Nicolas Villain / Moved to LinkedIn & BlueSky @VincentPlanche Prof Scott Ayton Sarah Ackley, PhD

Oh dear...

Seems like donanemab does about the same as lecanemab per centiloid: About -0.08 CDR-SB per 10 centiloids vs. -0.076 for CLARITY-AD (lecanemab) and -0.043 or  GRADUATE I & II (gantenerumab)

With a cat vomit on my bed and another one on my backpack, we've official entered fall fur ball season.

#DYK: Discontinuing #metformin may pose a higher risk of cognitive decline in aging patients with #diabetes. According to Boston University School of Public Health epidemiologist Sarah Ackley, PhD, staying on metformin can potentially prevent or delay the onset of #dementia. U.S. News & World Report spr.ly/6010uWqK2